Lv7
4980 积分 2024-03-16 加入
On assessing survival benefit of immunotherapy using long‐term restricted mean survival time
1天前
已完结
Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study
6天前
已完结
Estimating Differences in Restricted Mean Lifetime Using Observational Data Subject to Dependent Censoring
29天前
已关闭
Inference for Cumulative Incidences and Treatment Effects in Randomized Controlled Trials with Time-to-Event Outcomes under ICH E9 (R1)
1个月前
已完结
Doubly-robust estimator of the difference in restricted mean times lost with competing risks data
1个月前
已完结
Sensitivity analysis for unmeasured confounding in estimating the difference in restricted mean survival time
2个月前
已完结
Generalized mean residual life models for survival data with missing censoring indicators
2个月前
已完结
Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure
2个月前
已关闭
Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure
2个月前
已关闭
Sample size calculation for mixture cure model with restricted mean survival time as a primary endpoint
4个月前
已完结
皖公网安备34019202002308
